دورية أكاديمية

Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck

التفاصيل البيبلوغرافية
العنوان: Safety, biodistribution, pharmacokinetics, and immunogenicity of 99mTc-labeled humanized monoclonal antibody BIWA 4 (bivatuzumab) in patients with squamous cell carcinoma of the head and neck
المؤلفون: Colnot, David R., Roos, Jan C., de Bree, Remco, Wilhelm, Abraham J., Kummer, J. Alain, Hanft, Gertraud, Heider, Karl-Heinz, Stehle, Gerd, Snow, Gordon B., van Dongen, Guus A. M. S.
المصدر: Cancer Immunology, Immunotherapy. September 2003 52(9):576-582
قاعدة البيانات: Springer Nature Journals
الوصف
تدمد:03407004
14320851
DOI:10.1007/s00262-003-0396-5